Page 1317 - Small Animal Internal Medicine, 6th Edition
P. 1317

CHAPTER 78   Approach to the Patient With a Mass   1289


            requires general anesthesia and is more expensive. Plain
            radiographs of the affected area may also be indicated to look
  VetBooks.ir  for soft tissue and bone involvement. Abdominal ultrasonog-
            raphy or CT may be indicated for further staging in patients
            with certain neoplasms (e.g., hemangiosarcoma, intestinal
            neoplasms, mast cell tumors). A minimum database con-
            sisting of a CBC, serum biochemistry profile, and urinalysis
            may provide additional clinical information (e.g., paraneo-
            plastic syndromes, concurrent organ failure), and assess the
            general health of the patient in preparation for potential
            treatment.
              If the mass is malignant and there is no evidence of meta-
            static disease, surgical excision is usually recommended. If
            there are systemic or metastatic lesions, the pathologist feels
            comfortable with the cytologic diagnosis, and the tumor is   A
            likely to respond to chemotherapy (e.g., lymphoma, heman-
            giosarcoma), chemotherapy constitutes the best viable option
            (see Chapter 75). However, as discussed in Chapter 75, surgi-
            cal resection of the primary mass (e.g., mammary carci-
            noma) in a patient with metastatic lesions may provide
            considerable palliation and prolong good-quality survival. If
            an assertive diagnosis cannot be made on the basis of the
            cytologic findings, an incisional or excisional biopsy of the
            mass is advisable. The authors’ clinics almost never recom-
            mend euthanasia in dogs and cats with metastatic lesions
            and good quality of life because survival times in excess of 6
            months (without chemotherapy) are common in animals
            with most metastatic neoplasms. Metronomic chemotherapy
            may result in long-standing stable or slowly progressive
            metastatic disease (Fig. 78.1).
                                                                  B       L

            APPROACH TO THE PATIENT WITH                         FIG 78.1
            METASTATIC LESIONS                                   Thoracic radiographs in a 10-year-old, mixed-breed dog
                                                                 with a nonresectable thyroid carcinoma before (A) and
            Radiographic or ultrasonographic evidence of metastatic   after 756 days of metronomic chemotherapy (B).
            cancer is occasionally found during the routine evaluation
            of an animal with a suspected or confirmed malignancy, or   A cytologic diagnosis of metastatic lung lesions can
            during the evaluation of a cat or dog with obscure clinical   usually be obtained through blind or ultrasonography-, fluo-
            signs. In such instances, the clinician should be familiar with   roscopy-, or CT-guided percutaneous FNA of the lungs. To
            both the biologic behavior of the common neoplasms and   do this, the area to be aspirated (i.e., the one with the highest
            with their characteristic radiographic and ultrasonographic   density  of  lesions  radiographically  or  the  easily  identified
            patterns (Table 78.1). Suter et al. (1974) described the typical   and accessible lesions) is clipped and aseptically prepared.
            radiographic appearances of various metastatic malignan-  For blind percutaneous lung aspirates, the patient should be
            cies. In addition, the owner should be questioned regarding   in sternal recumbency or standing; a 25- or 27-gauge, 2- to
            any prior surgeries in the pet (e.g., excision of a mass that   3-inch (5- to 7.5-cm) needle (depending on the size of the
            was thought to be benign but may have been the primary   animal) coupled to a 12- to 20-mL syringe is rapidly advanced
            malignancy).                                         through an intercostal space along the cranial border of the
              If a cytologic or histopathologic diagnosis of malignancy   rib to the depth required (previously determined on the basis
            has already been made and the metastatic lesions are detected   of the radiographs), and suction is applied two or three times
            while staging the patient, treatment options can be discussed   and then released; the needle is then withdrawn. Smears are
            with the owner at this point (assuming that the metastatic   made as described in Chapter 74. When aspirating lungs, the
            lesions have arisen from the previously diagnosed primary   clinician is likely to obtain a fair amount of air or blood (or
            tumor). As a general rule, cytologic or histopathologic evalu-  both) in the syringe. Rare complications associated with this
            ation of one or more of these lesions should be performed   technique include pneumothorax (patients should be closely
            so that the clinician can best advise the owner as to the   observed for 2-6 hours after the procedure and dealt with
            appropriate course of action.                        accordingly if pneumothorax develops) and bleeding. As a
   1312   1313   1314   1315   1316   1317   1318   1319   1320   1321   1322